BOND ORACLE HER2 IHC SYSTEM

System, Test, Her-2/neu, Ihc

FDA Premarket Approval P090015

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the bond oracle her2 ihc system. This device is indicated for: bond oracle her2 ihc system is a semi-quantitative immunohistochemical (ihc) assay to determine her2 (human epidermal growth factor receptor 2) oncoprotein status in formalin-fixed, parrafin embedded breast cancer tissue processed for histological evaluation following automated staining on the bond-max slide staining instrument. The bond oracle her2 ihc system is indicated as an aid in the assessment of patients for whom herceptin (trastuzumab) treatment is being considered.

DeviceBOND ORACLE HER2 IHC SYSTEM
Classification NameSystem, Test, Her-2/neu, Ihc
Generic NameSystem, Test, Her-2/neu, Ihc
ApplicantLeica Biosystems
Date Received2009-07-22
Decision Date2012-04-18
Notice Date2012-04-25
PMAP090015
SupplementS
Product CodeMVC
Docket Number12M-0390
Advisory CommitteePathology
Expedited ReviewNo
Combination Product Yes
Applicant Address Leica Biosystems 36 Cherry Hill Drive danvers, MA 01923
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P090015Original Filing
S012 2020-08-28 30-day Notice
S011 2020-04-02 30-day Notice
S010 2019-12-13 30-day Notice
S009 2019-09-09 30-day Notice
S008 2019-07-24 30-day Notice
S007 2019-04-01 30-day Notice
S006 2018-10-26 Real-time Process
S005 2017-06-27 30-day Notice
S004 2017-02-02 30-day Notice
S003 2015-04-20 Special (immediate Track)
S002 2014-11-28 Real-time Process
S001 2013-07-26 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.